No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45
UBS Initiates Qiagen NV(QGEN.US) With Hold Rating
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?
Baird Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $43
Baird Maintains Neutral on Qiagen, Raises Price Target to $43